News & Updates

Patients with Ebola virus disease (EVD) appear to experience neurological symptoms during acute infection and numerous neurological sequelae during recovery, according to a study.

A multidomain, systematic lifestyle intervention (SLI) may yield a significantly greater improvement in global cognitive function over 2 years compared with a flexible lifestyle intervention (FLI) among older adults at high risk of dementia, according to the LatAm-FINGERS* trial presented at AAIC 2026.

Anaemia in patients with acute ischaemic stroke (AIS) is associated with an increased risk of death both in the short and long term, as shown in a local study.

Empiric antibiotic prescription patterns vary substantially in children with cerebrospinal fluid (CSF) shunt infection, and overuse is not uncommon, a study has found.

Among patients with rheumatoid arthritis (RA), treatment with immunosuppressants may partly attenuate the risk of Alzheimer’s disease, according to a study.

Physical activity helps lower the risks of stroke and mortality, regardless of the presence of atrial fibrillation (AF), according to the Norwegian population-based Tromsø and HUNT studies.

Spouses of individuals with dementia appear to have an increased likelihood of developing the condition themselves, according to a study from Taiwan.

Use of direct oral anticoagulants (DOACs) vs warfarin appears to increase the 1-year risk for stroke but lower the risk for myocardial infarction (MI) in Asian patients with atrial fibrillation (AF) and mitral stenosis (MS), according to a study.

Hypertension and diabetes in midlife have been associated with increased risk of early-onset dementia, specifically the non-Alzheimer’s type, in a population-based case-control study.

Gefurulimab, a novel bispecific nanobody that targets complement factor 5 (C5) delivers rapid and sustained clinical benefit in patients with anti–acetylcholine receptor antibody–positive (AChR-Ab+) generalized myasthenia gravis (gMG), as shown in the phase III PREVAIL trial.